BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding L, De Munck TJI, Oligschlaeger Y, dos Reis IM, Verbeek J, Koek GH, Houben T, Shiri-sverdlov R. Myosteatosis in NAFLD patients correlates with plasma Cathepsin D. Biomolecular Concepts 2021;12:27-35. [DOI: 10.1515/bmc-2021-0004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cespiati A, Meroni M, Lombardi R, Oberti G, Dongiovanni P, Fracanzani AL. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 2022;10:182. [DOI: 10.3390/biomedicines10010182] [Reference Citation Analysis]
2 Wang S, Jiu Lüe H, Zhao J. Study on Syndrome Intervention of Nonalcoholic Fatty Liver Disease from the Perspective of Deficiency and Excess. J Healthc Eng 2021;2021:9928160. [PMID: 34567490 DOI: 10.1155/2021/9928160] [Reference Citation Analysis]
3 Ding L, De Munck TJI, Oligschlaeger Y, Verbeek J, Koek GH, Houben T, Shiri-Sverdlov R. Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients. Biomol Concepts 2021;12:110-5. [PMID: 34370929 DOI: 10.1515/bmc-2021-0011] [Reference Citation Analysis]